NIH reels with fear, uncertainty about future of scientific research
The Trump administration’s orders have created more turmoil and damage at the National Institutes of Health than was ...
News Medical on MSN2d
NIH Reports Omalizumab Treats Multi-Food Allergy Better Than Oral Immunotherapy
Omalizumab works by binding to the allergy-causing antibody called immunoglobulin E in the blood and preventing it from ...
Research identifies key antibodies for development of broadly protective norovirus vaccine
Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their ...
Breakthrough Treatment Helps Food Allergy Sufferers Tolerate More Allergens
The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...
Mirage News4d
New Drug vs. Oral Therapy: Food Allergy Study Results
New research, led by Johns Hopkins Children's Center investigators and sponsored by the National Institutes of Health's (NIH) ...
Technology Networks4d
Omalizumab Treats Food Allergy More Effectively Than Immunotherapy
In a new study, omalizumab, an injectable drug for food allergies, performed better than oral immunotherapy. A subsequent ...
News Medical on MSN2d
Feeding infants diverse foods early may cut allergy risk, study reveals
Early dietary diversity in infants may reduce the risk of food allergies by promoting immune tolerance and gut microbiome ...
NIH director nominee outlines his goals to improve public health
A relatively sedate Senate Health, Education, Labor and Pensions Committee confirmation hearing for National Institutes of Health Director-nominee Dr. Jay Bhattacharya revealed his five goals to ...
Omalizumab treats multi-food allergy better than oral immunotherapy, study finds
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively ...